These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 32391667)

  • 1. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
    Chen J; Liu D; Liu L; Liu P; Xu Q; Xia L; Ling Y; Huang D; Song S; Zhang D; Qian Z; Li T; Shen Y; Lu H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(2):215-219. PubMed ID: 32391667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.
    Satlin MJ; Goyal P; Magleby R; Maldarelli GA; Pham K; Kondo M; Schenck EJ; Rennert H; Westblade LF; Choi JJ; Safford MM; Gulick RM
    PLoS One; 2020; 15(7):e0236778. PubMed ID: 32701969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis.
    Sarma P; Kaur H; Kumar H; Mahendru D; Avti P; Bhattacharyya A; Prajapat M; Shekhar N; Kumar S; Singh R; Singh A; Dhibar DP; Prakash A; Medhi B
    J Med Virol; 2020 Jul; 92(7):776-785. PubMed ID: 32297988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.
    Catteau L; Dauby N; Montourcy M; Bottieau E; Hautekiet J; Goetghebeur E; van Ierssel S; Duysburgh E; Van Oyen H; Wyndham-Thomas C; Van Beckhoven D;
    Int J Antimicrob Agents; 2020 Oct; 56(4):106144. PubMed ID: 32853673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
    Abd-Elsalam S; Esmail ES; Khalaf M; Abdo EF; Medhat MA; Abd El Ghafar MS; Ahmed OA; Soliman S; Serangawy GN; Alboraie M
    Am J Trop Med Hyg; 2020 Oct; 103(4):1635-1639. PubMed ID: 32828135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease.
    Mallat J; Hamed F; Balkis M; Mohamed MA; Mooty M; Malik A; Nusair A; Bonilla MF
    Medicine (Baltimore); 2020 Dec; 99(52):e23720. PubMed ID: 33350752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
    Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
    Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial.
    Davoodi L; Abedi SM; Salehifar E; Alizadeh-Navaei R; Rouhanizadeh H; Khorasani G; Hosseinimehr SJ
    Int J Clin Pract; 2020 Nov; 74(11):e13600. PubMed ID: 32603531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine and COVID-19: Lack of Efficacy and the Social Construction of Plausibility.
    Rughiniş C; Dima L; Vasile S
    Am J Ther; 2020; 27(6):e573-e583. PubMed ID: 33136577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
    Nina PB; Dash AP
    Indian J Public Health; 2020 Jun; 64(Supplement):S125-S127. PubMed ID: 32496241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
    Oscanoa TJ; Romero-Ortuno R; Carvajal A; Savarino A
    Int J Antimicrob Agents; 2020 Sep; 56(3):106078. PubMed ID: 32629115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
    Rodrigo C; Fernando SD; Rajapakse S
    Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and imaging findings of discharged patients with SARS-CoV-2 positive anal swab samples: a descriptive study.
    Zhou H; Zhu L; Leng Y; Wang D; Bai HX; Xiong Z; Shi L; Liao W
    BMC Infect Dis; 2020 Sep; 20(1):644. PubMed ID: 32873230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study.
    Kamalov AA; Mareev VY; Orlova YA; Plisyk AG; Akopyan ZA; Mareev YV; Mershina EA; Begrambekova YL; Pakhomov PV
    Kardiologiia; 2021 Mar; 61(2):28-39. PubMed ID: 33734044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19.
    Yu B; Li C; Chen P; Zhou N; Wang L; Li J; Jiang H; Wang DW
    Sci China Life Sci; 2020 Oct; 63(10):1515-1521. PubMed ID: 32418114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with COVID-19.
    Falcão MB; Pamplona de Góes Cavalcanti L; Filgueiras Filho NM; Antunes de Brito CA
    Am J Trop Med Hyg; 2020 Jun; 102(6):1214-1216. PubMed ID: 32314698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
    Marzolini C; Stader F; Stoeckle M; Franzeck F; Egli A; Bassetti S; Hollinger A; Osthoff M; Weisser M; Gebhard CE; Baettig V; Geenen J; Khanna N; Tschudin-Sutter S; Mueller D; Hirsch HH; Battegay M; Sendi P
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32641296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
    Fatima U; Rizvi SSA; Fatima S; Hassan MI
    J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
    Lian N; Xie H; Lin S; Huang J; Zhao J; Lin Q
    Clin Microbiol Infect; 2020 Jul; 26(7):917-921. PubMed ID: 32344167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of hydroxychloroquine in blood from SLE patients using LC-HRMS-evaluation of whole blood, plasma, and serum as sample matrices.
    Carlsson H; Hjorton K; Abujrais S; Rönnblom L; Åkerfeldt T; Kultima K
    Arthritis Res Ther; 2020 Jun; 22(1):125. PubMed ID: 32475347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.